With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences | With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences arm.

While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and more continue to dog the industry, even as…

Merck übernimmt den US-Laborausrüster Bio-Techne für 9,9 Milliarden – ein Zukauf, auf den Investoren und Analysten seit Jahren warten. Der neue Konzernchef sieht derweil weitere…